Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.42 EUR | -2.89% | -5.31% | -11.00% |
Sep. 06 | Barclays rates BASF at 'Equal Weight' - Target 57 euros | DP |
Sep. 06 | BASF SE : Barclays remains Neutral | ZD |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 59.32B | 59.15B | 78.6B | 87.33B | 68.9B | |||||
Total Revenues | 59.32B | 59.15B | 78.6B | 87.33B | 68.9B | |||||
Cost of Goods Sold, Total | 43.35B | 44.38B | 59.09B | 66.7B | 52.51B | |||||
Gross Profit | 15.97B | 14.77B | 19.51B | 20.63B | 16.4B | |||||
Selling General & Admin Expenses, Total | 9.38B | 8.84B | 9.9B | 11.2B | 10.38B | |||||
Exploration / Drilling Costs, Total | - | - | - | - | - | |||||
Stock-Based Compensation (IS) | 39M | 35M | 37M | - | - | |||||
R&D Expenses | 2.16B | 2.09B | 2.22B | 2.3B | 2.13B | |||||
Other Operating Expenses | 704M | 709M | -115M | 275M | 1.02B | |||||
Other Operating Expenses, Total | 12.28B | 11.66B | 12.04B | 13.77B | 13.53B | |||||
Operating Income | 3.69B | 3.1B | 7.47B | 6.86B | 2.87B | |||||
Interest Expense, Total | -648M | -557M | -506M | -631M | -868M | |||||
Interest And Investment Income | 216M | 356M | 257M | 354M | 453M | |||||
Net Interest Expenses | -432M | -201M | -249M | -277M | -415M | |||||
Income (Loss) On Equity Invest. | 116M | -705M | 960M | -4.5B | 78M | |||||
Currency Exchange Gains (Loss) | -162M | -120M | -109M | -152M | -327M | |||||
Other Non Operating Income (Expenses) | -72M | 40M | -72M | -20M | -93M | |||||
EBT, Excl. Unusual Items | 3.14B | 2.12B | 8B | 1.91B | 2.11B | |||||
Restructuring Charges | -654M | -1.1B | -433M | -486M | -628M | |||||
Merger & Related Restructuring Charges | -43M | -90M | -28M | - | - | |||||
Gain (Loss) On Sale Of Investments | -86M | -175M | -114M | -107M | -112M | |||||
Gain (Loss) On Sale Of Assets | 806M | 11M | 129M | 250M | 43M | |||||
Asset Writedown | 6M | -2.37B | -103M | -375M | 6M | |||||
Insurance Settlements | 44M | - | - | - | - | |||||
Legal Settlements | -18M | -116M | - | - | - | |||||
Other Unusual Items | 111M | 157M | - | - | - | |||||
EBT, Incl. Unusual Items | 3.3B | -1.56B | 7.45B | 1.19B | 1.42B | |||||
Income Tax Expense | 756M | -91M | 1.43B | 1.58B | 1.04B | |||||
Earnings From Continuing Operations | 2.55B | -1.47B | 6.02B | -391M | 379M | |||||
Earnings Of Discontinued Operations | 5.94B | 396M | -36M | - | - | |||||
Net Income to Company | 8.49B | -1.08B | 5.98B | -391M | 379M | |||||
Minority Interest | -70M | 15M | -459M | -236M | -154M | |||||
Net Income - (IS) | 8.42B | -1.06B | 5.52B | -627M | 225M | |||||
Net Income to Common Incl Extra Items | 8.42B | -1.06B | 5.52B | -627M | 225M | |||||
Net Income to Common Excl. Extra Items | 2.48B | -1.46B | 5.56B | -627M | 225M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 9.17 | -1.15 | 6.01 | -0.7 | 0.25 | |||||
Basic EPS - Continuing Operations | 2.7 | -1.59 | 6.05 | -0.7 | 0.25 | |||||
Basic Weighted Average Shares Outstanding | 918M | 918M | 918M | 902M | 893M | |||||
Net EPS - Diluted | 9.15 | -1.15 | 6 | -0.7 | 0.25 | |||||
Diluted EPS - Continuing Operations | 2.69 | -1.59 | 6.04 | -0.7 | 0.25 | |||||
Diluted Weighted Average Shares Outstanding | 920M | 920M | 920M | 902M | 895M | |||||
Normalized Basic EPS | 2.06 | 1.46 | 4.94 | 1.06 | 1.31 | |||||
Normalized Diluted EPS | 2.05 | 1.45 | 4.93 | 1.06 | 1.3 | |||||
Dividend Per Share | 3.3 | 3.3 | 3.4 | 3.4 | 3.4 | |||||
Payout Ratio | 34.9 | -285.94 | 54.88 | -489.95 | 1.35K | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 7.07B | 6.97B | 11.01B | 10.23B | 6.21B | |||||
EBITA | 3.69B | 3.1B | 7.47B | 7.48B | 3.45B | |||||
EBIT | 3.69B | 3.1B | 7.47B | 6.86B | 2.87B | |||||
EBITDAR | 7.28B | 7.16B | 11.2B | 10.42B | 6.41B | |||||
Effective Tax Rate - (Ratio) | 22.9 | 5.83 | 19.2 | 132.86 | 73.31 | |||||
Total Current Taxes | 1.05B | 398M | 1.44B | 1.28B | 1.1B | |||||
Total Deferred Taxes | -297M | -489M | -6M | 301M | -61M | |||||
Normalized Net Income | 1.89B | 1.34B | 4.54B | 956M | 1.17B | |||||
Interest Capitalized | 35M | 30M | 29M | 40M | 80M | |||||
Interest on Long-Term Debt | 39M | 36M | 36M | 40M | 53M | |||||
Non-Cash Pension Expense | 377M | 538M | 505M | 438M | 316M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 7.91B | 7.5B | 8.41B | 9.61B | 8.79B | |||||
General and Administrative Expenses | 1.31B | 1.23B | 1.41B | 1.52B | 1.51B | |||||
Research And Development Expense From Footnotes | 2.16B | 2.09B | 2.22B | 2.3B | 2.13B | |||||
Exploration/Drilling Costs | - | - | - | - | - | |||||
Net Rental Expense, Total | 207M | 186M | 186M | 191M | 197M | |||||
Imputed Operating Lease Interest Expense | 54.09M | 42.02M | 39.48M | 51.15M | 70.65M | |||||
Imputed Operating Lease Depreciation | 153M | 144M | 147M | 140M | 126M | |||||
Stock-Based Comp., Other (Total) | 72M | 63M | 64M | 20M | 26M | |||||
Total Stock-Based Compensation | 72M | 63M | 64M | 20M | 26M |